2025-05-11 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Review

**0. Executive Summary:**

Colgate-Palmolive Co (CL) is a leading consumer goods company specializing in oral hygiene, personal care, and household products.  Recent performance shows underperformance against the S&P 500 (VOO), with a negative alpha and concerningly high ROE fluctuations.  Short-term indicators suggest a bearish trend, but long-term prospects require further investigation.

**1. Performance Comparison with S&P 500:**

Colgate-Palmolive (CL) shows a cumulative return of 34.14% compared to 87.98% for the S&P 500 (VOO) over the analyzed period. This represents a significant underperformance of -53.8%, placing it at the 17.3rd percentile relative to its historical range of underperformance against the S&P 500 (-66.7% to 7.8%).


**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 16.0% | 4.2% | -16.0% | 0.1 | 50.6 |
| 2016-2018  | -9.0% | 65.3% | -30.0% | 0.1 | 40.9 |
| 2017-2019  | 10.0% | 65.3% | -24.0% | -0.3 | 48.5 |
| 2018-2020  | 22.0% | 65.3% | -8.0% | 0.3 | 61.7 |
| 2019-2021  | 34.0% | 58.5% | -26.0% | 0.8 | 63.0 |
| 2020-2022  | 11.0% | 68.9% | 2.0% | 0.7 | 59.5 |
| 2021-2023  | 8.0% | 68.9% | -13.0% | 0.6 | 61.8 |
| 2022-2024  | 16.0% | 68.9% | -5.0% | 0.5 | 72.0 |
| 2023-2025  | 11.0% | 73.0% | 0.2 | 0.5 | 72.8 |

The alpha is consistently negative or very low in most periods, indicating underperformance compared to the market benchmark. The beta fluctuates, suggesting varying levels of market sensitivity.

**2. Recent Price Movement:**

* **Closing Price:** $90.83
* **Last Market Price:** $89.81 (Down $1.12)
* **5-Day Moving Average:** $90.79
* **20-Day Moving Average:** $92.63
* **60-Day Moving Average:** $91.21

The stock price is below all three moving averages, suggesting a bearish short-term trend. The recent price drop (-1.12) should be considered in further analysis.


**3. Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.37 (Medium Risk)
* **RSI:** 32.16 (Oversold, indicating potential bounce but also continued downside risk)
* **PPO:** -0.37 (Bearish signal)
* **20-Day Relative Strength Change:** -2.8% (Short-term bearish)
* **Expected Return:** -180.1% (This extremely negative value needs clarification and likely reflects an error in the calculation or data input.)

The technical indicators paint a mixed picture, but predominantly bearish in the short-term. The extremely negative expected return requires further investigation to determine its validity.


**4. Recent Earnings Analysis:**

| Date       | EPS    | Revenue      |
|------------|--------|---------------|
| 2025-04-25 | $0.85  | $4.91 Billion |
| 2024-10-25 | $0.90  | $5.03 Billion |
| 2024-07-26 | $0.89  | $5.06 Billion |
| 2024-04-26 | $0.83  | $5.07 Billion |
| 2025-04-25 | $0.83  | $5.07 Billion | *(Duplicate entry?)*


Revenue is relatively stable around $5 Billion. EPS shows minor fluctuations, but no clear trend.  The duplicate entry for 2025-04-25 needs clarification.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-03-31 | $4.91B | 60.82% |
| 2024-12-31 | $4.95B | 60.30% |
| 2024-09-30 | $5.03B | 61.08% |
| 2024-06-30 | $5.06B | 60.62% |
| 2024-03-31 | $5.07B | 60.00% |

Profit margins are consistently high and relatively stable.  Revenue shows minor fluctuation.


**Capital and Profitability:**

| Quarter | Equity   | ROE         |
|---------|----------|-------------|
| 2025-03-31 | $0.36B  | 190.08%     |
| 2024-12-31 | $0.21B  | 348.58%     |
| 2024-09-30 | $0.43B  | 169.43%     |
| 2024-06-30 | $0.12B  | 594.31%     |
| 2024-03-31 | $0.23B  | 296.96%     |

ROE is highly volatile and exceptionally high in some quarters, possibly indicating accounting irregularities or unusual financial activities that need further investigation. This is a major red flag.


**6. Overall Analysis:**

Colgate-Palmolive (CL) shows consistent profitability and relatively stable revenue. However, the stock has significantly underperformed the S&P 500, showing a negative alpha over multiple periods.  Technical indicators suggest a short-term bearish trend. The high volatility and unusually high ROE figures raise serious concerns regarding the company's financial health and reporting practices.  Further investigation is crucial before making any investment decision.  The extremely negative expected return needs to be validated.  Professional financial advice should be sought before investing.
